AREV Life Sciences Global Corp.
AREVF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,444 | -$990 | -$1,049 | -$3,193 |
| Dep. & Amort. | $126 | $146 | $149 | $66 |
| Deferred Tax | $0 | -$809 | $280 | $93 |
| Stock-Based Comp. | $144 | $455 | $106 | $1,061 |
| Change in WC | $850 | -$370 | $424 | $620 |
| Other Non-Cash | $40 | $97 | $67 | $1,239 |
| Operating Cash Flow | -$284 | -$1,470 | -$24 | -$114 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$27 | -$66 | -$456 | -$215 |
| Net Acquisitions | $0 | $60 | $20 | $0 |
| Inv. Purchases | $0 | $0 | $75 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $20 | $0 |
| Other Inv. Act. | -$55 | $11 | -$95 | $0 |
| Investing Cash Flow | -$82 | $5 | -$436 | -$215 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $5 | $314 | -$53 | $100 |
| Stock Issued | $202 | $665 | $450 | $250 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $203 | $303 | $330 | $0 |
| Financing Cash Flow | $208 | $1,282 | $728 | $350 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$158 | -$139 | $268 | $21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $158 | $298 | $30 | $8 |
| End Cash | $0 | $158 | $298 | $30 |
| Free Cash Flow | -$366 | -$1,482 | -$480 | -$329 |